Deal · Agreement signed
Werewolf Therapeutics, Inc. and Ambros Therapeutics
First filed 21 Aug 2026, 1 filing.
The deal
- Buyer
- Werewolf Therapeutics, Inc.
- Target
- Ambros Therapeutics
- Status
- Agreement signed
- Region
- US
Entry into a Material Definitive Agreement Merger Agreement On August 21, 2026, Werewolf Therapeutics, Inc., a Delaware corporation ("Werewolf"), entered into an Agreement and Plan of Merger (the "Merger Agreement") by and among Ambros Therapeutics, Inc., a Delaware corporation ("Ambros"), Werewolf, and Wave Atlantis Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary...
Source: The filing (SEC Form 8-K)
With a free account
A free account opens 10 full pages a month and lets you follow this page: alerts on the next filing, buyer lists, exports.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.